Learn more

REGENERX BIOPHARMACEUTICALS

Overview
  • Total Patents
    151
  • GoodIP Patent Rank
    241,198
About

REGENERX BIOPHARMACEUTICALS has a total of 151 patent applications. Its first patent ever was published in 2001. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are REGENERX BIOPHARMACEUTICALS INC, LA JOLLA PHARMA CO and KTB TUMORFORSCHUNGS GMBH.

Patent filings per year

Chart showing REGENERX BIOPHARMACEUTICALSs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Goldstein Allan L 100
#2 Crockford David 49
#3 Finkelstein Jack Jr 28
#4 Sosne Gabriel 27
#5 Hannappel Ewald 15
#6 Huff Thomas 11
#7 Allan Christian B 11
#8 Lyons C Neil 8
#9 Finkelstein Jr Jack 5
#10 David Crockford 5

Latest patents

Publication Filing date Title
CA2811977A1 Method of achieving a thymosin beta 4 concentration in a human patient
US2011020449A1 Methods of treating disorders of the eye and surrounding tissue with thymosin beta 4 (tb4), analogues, isoforms and other derivatives
CA2718774A1 Improved beta thymosin fragments
AU2008201749A1 Treatment of Infections and Other Disorders
WO2008108927A2 Methods and compositions for stabilizing polypeptides
EP2076277A2 Method of treating or preventing tissue deterioration, injury or damage due to periodontal disease or disease of oral mucosa, and/or downregulating nf-kappab or suppressing nf-kappab-mediated actions
US2008096817A1 METHODS OF TREATING DISORDERS OF THE EYE AND SURROUNDING TISSUE WITH THYMOSIN BETA 4 (Tbeta4), ANALOGUES, ISOFORMS AND OTHER DERIVATIVES
KR20090049605A Methods and compositions for conserving and/or preparing an organ or tissue for transplant
WO2008024194A2 Method of conserving and preparing tissue or cells for transfer, transplant, re-implantation, further study or the like
US2008051348A1 Treatment of infections and other disorders
WO2007027578A2 Methods and compositions for decreasing cohesivity of pathological respiratory tract secretions
CA2616521A1 Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure
WO2007014254A2 Method of treating or preventing tissue deterioration, injury or damage due to hypertrophic muscle disease
MX2007015956A Lkktet and/or lkktnt compositions and methods for treating or preventing tissue deterioration, injury or damage.
CN101198344A LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized
EP1835927A1 Modified beta thymosin peptides
CN101119741A Modified beta thymosin peptides
CN101102784A Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease
WO2006076255A2 Method of treating or preventing microbial eye infection
US2007015698A1 Treatment of skin, and wound repair, with thymosin beta 4